TENNESSEE RETINA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1978-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.tnretina.com/
Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- Tennessee Retina
- Target Recruit Count
- 22
- Registration Number
- NCT03468296
- Locations
- 🇺🇸
Tennessee Retina, Nashville, Tennessee, United States
Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy
- First Posted Date
- 2013-05-20
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- Tennessee Retina
- Target Recruit Count
- 10
- Registration Number
- NCT01857544
- Locations
- 🇺🇸
Tennessee Retina, PC, Nashville, Tennessee, United States
On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- Tennessee Retina
- Target Recruit Count
- 30
- Registration Number
- NCT01670162
- Locations
- 🇺🇸
Pacific Eye Associates, San Fransisco, California, United States
🇺🇸Retina Associates of Kentucky, Lexington, Kentucky, United States
🇺🇸Tennessee Retina, P.C., Nashville, Tennessee, United States
© Copyright 2024. All Rights Reserved by MedPath